LMAT
Price
$91.76
Change
+$2.22 (+2.48%)
Updated
Apr 24 closing price
Capitalization
1.48B
6 days until earnings call
TNDM
Price
$17.67
Change
+$1.10 (+6.64%)
Updated
Apr 24 closing price
Capitalization
2.32B
5 days until earnings call
Ad is loading...

LMAT vs TNDM

Header iconLMAT vs TNDM Comparison
Open Charts LMAT vs TNDMBanner chart's image
LeMaitre Vascular
Price$91.76
Change+$2.22 (+2.48%)
Volume$137.23K
Capitalization1.48B
Tandem Diabetes Care
Price$17.67
Change+$1.10 (+6.64%)
Volume$1.36M
Capitalization2.32B
LMAT vs TNDM Comparison Chart
Loading...
LMAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TNDM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LMAT vs. TNDM commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LMAT is a StrongBuy and TNDM is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (LMAT: $91.76 vs. TNDM: $17.67)
Brand notoriety: LMAT and TNDM are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: LMAT: 56% vs. TNDM: 70%
Market capitalization -- LMAT: $1.48B vs. TNDM: $2.32B
LMAT [@Medical Specialties] is valued at $1.48B. TNDM’s [@Medical Specialties] market capitalization is $2.32B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LMAT’s FA Score shows that 1 FA rating(s) are green whileTNDM’s FA Score has 0 green FA rating(s).

  • LMAT’s FA Score: 1 green, 4 red.
  • TNDM’s FA Score: 0 green, 5 red.
According to our system of comparison, LMAT is a better buy in the long-term than TNDM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LMAT’s TA Score shows that 4 TA indicator(s) are bullish while TNDM’s TA Score has 5 bullish TA indicator(s).

  • LMAT’s TA Score: 4 bullish, 5 bearish.
  • TNDM’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, TNDM is a better buy in the short-term than LMAT.

Price Growth

LMAT (@Medical Specialties) experienced а +6.35% price change this week, while TNDM (@Medical Specialties) price change was +4.80% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +4.80%. For the same industry, the average monthly price growth was -6.16%, and the average quarterly price growth was -2.09%.

Reported Earning Dates

LMAT is expected to report earnings on Jul 24, 2025.

TNDM is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Medical Specialties (+4.80% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TNDM($2.32B) has a higher market cap than LMAT($1.48B). TNDM has higher P/E ratio than LMAT: TNDM (666.67) vs LMAT (49.19). LMAT YTD gains are higher at: -0.168 vs. TNDM (-50.944). LMAT has higher annual earnings (EBITDA): 49M vs. TNDM (-196.97M). TNDM has more cash in the bank: 468M vs. LMAT (105M). LMAT has less debt than TNDM: LMAT (19.1M) vs TNDM (416M). TNDM has higher revenues than LMAT: TNDM (748M) vs LMAT (193M).
LMATTNDMLMAT / TNDM
Capitalization1.48B2.32B64%
EBITDA49M-196.97M-25%
Gain YTD-0.168-50.9440%
P/E Ratio49.19666.677%
Revenue193M748M26%
Total Cash105M468M22%
Total Debt19.1M416M5%
FUNDAMENTALS RATINGS
LMAT vs TNDM: Fundamental Ratings
LMAT
TNDM
OUTLOOK RATING
1..100
2053
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
99
Overvalued
PROFIT vs RISK RATING
1..100
12100
SMR RATING
1..100
5794
PRICE GROWTH RATING
1..100
4693
P/E GROWTH RATING
1..100
4493
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LMAT's Valuation (66) in the Medical Specialties industry is somewhat better than the same rating for TNDM (99). This means that LMAT’s stock grew somewhat faster than TNDM’s over the last 12 months.

LMAT's Profit vs Risk Rating (12) in the Medical Specialties industry is significantly better than the same rating for TNDM (100). This means that LMAT’s stock grew significantly faster than TNDM’s over the last 12 months.

LMAT's SMR Rating (57) in the Medical Specialties industry is somewhat better than the same rating for TNDM (94). This means that LMAT’s stock grew somewhat faster than TNDM’s over the last 12 months.

LMAT's Price Growth Rating (46) in the Medical Specialties industry is somewhat better than the same rating for TNDM (93). This means that LMAT’s stock grew somewhat faster than TNDM’s over the last 12 months.

LMAT's P/E Growth Rating (44) in the Medical Specialties industry is somewhat better than the same rating for TNDM (93). This means that LMAT’s stock grew somewhat faster than TNDM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LMATTNDM
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
81%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
65%
Bullish Trend 1 day ago
78%
Momentum
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
85%
MACD
ODDS (%)
Bullish Trend 1 day ago
80%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
78%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
71%
Bearish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
79%
Declines
ODDS (%)
Bearish Trend 18 days ago
55%
Bearish Trend 4 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
64%
Bullish Trend 1 day ago
85%
Aroon
ODDS (%)
Bearish Trend 1 day ago
57%
Bearish Trend 1 day ago
83%
View a ticker or compare two or three
Ad is loading...
LMAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TNDM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RNWBX75.070.82
+1.10%
American Funds New World R2
ALVCX20.93N/A
N/A
American Beacon Large Cap Value C
FBBYX25.82N/A
N/A
First Foundation Total Return Y
LRSPX11.51N/A
N/A
Lord Abbett Small Cap Value P
IAAEX10.32N/A
N/A
Transamerica Mid Cap Value Opps I2

LMAT and

Correlation & Price change

A.I.dvisor indicates that over the last year, LMAT has been loosely correlated with SYK. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if LMAT jumps, then SYK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LMAT
1D Price
Change %
LMAT100%
+2.48%
SYK - LMAT
48%
Loosely correlated
+1.10%
ITGR - LMAT
46%
Loosely correlated
+0.79%
AORT - LMAT
44%
Loosely correlated
+0.29%
MMSI - LMAT
42%
Loosely correlated
+0.97%
OFIX - LMAT
42%
Loosely correlated
+3.87%
More

TNDM and

Correlation & Price change

A.I.dvisor indicates that over the last year, TNDM has been loosely correlated with TFX. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if TNDM jumps, then TFX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TNDM
1D Price
Change %
TNDM100%
+6.64%
TFX - TNDM
52%
Loosely correlated
+1.98%
CLPT - TNDM
42%
Loosely correlated
+7.85%
AZTA - TNDM
37%
Loosely correlated
+5.16%
LMAT - TNDM
35%
Loosely correlated
+2.48%
SHC - TNDM
35%
Loosely correlated
+3.96%
More